As of 2024-12-15, the Relative Valuation of Mirati Therapeutics Inc (MRTX) is (185.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.70 USD, the upside of Mirati Therapeutics Inc based on Relative Valuation is -415.5%.
The range of the Relative Valuation is (185.22) - (197.02) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.3x - 27.6x | 17.3x |
| Forward P/E multiples | 17.9x - 19.0x | 18.5x |
| Fair Price | (185.22) - (197.02) | (185.22) |
| Upside | -415.5% - -435.6% | -415.5% |
| Date | P/E |